Adamis Pharmaceuticals (ADMP) Q2 2023 Earnings

21AugConfirmed
Nov 22
Q4 2022
Q1 2023
Q2 2023
-3.4
-2.27
-1.15
-0.02

Details

Expected EPS
N/A
Actual EPS
-3.4
Surprise EPS
-3.4
Surprise Percent
+∞%

Description

Adamis Pharmaceuticals (ADMP) has reported earnings of -3.4 per share for Q2 2023.

0 Comments

Share your thoughts